AstraZeneca diabetes drug cuts heart risks in major study

AstraZeneca's diabetes drug Farxiga met a key goal in a major clinical study designed to show its heart-protecting benefits in a wide range of patients, potentially distinguishing it from rivals in a crowded marketplace.

from Reuters: Health News https://ift.tt/2O3QsFd